A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia

Summary

This study is examining the efficacy of PF-03463275 compared to placebo in treating negative symptoms of schizophrenia when added to ongoing antipsychotic treatment in stable outpatients with schizophrenia.

Timeline

Start

2009-11

Primary completion

2010-09

Completion

2010-09

Outcome

Outcome not reported

Stopped: “See termination reason in detailed description.”

Drugs

Indications